Abstract:Introduction: Non-alcoholic fatty liver disease (NAFLD) has gradually become the primary cause of fatty liver disease. Betel nuts have been used to treat gastrointestinal diseases. Methods: In the present study, we analyzed the pathology, serology, gut flora, and metabolites in a rat model of NAFLD, with and without betel nut alkaloid treatment, using an integrated approach involving pathology, serological testing, 16S rRNA gene sequencing, and ultra-performance liquid chromatography-mass spectrometry metabolomics. Results: Two rats were used for model validation. Thirty SD rats were included and divided into the normal group (C group), NAFLD model group (M group), low-dose group, medium-dose group (T group), and high-dose group with intraperitoneal injection of arecoline. The expression of blood lipids was significantly downregulated at all three arecoline concentrations ( p < 0.05). Alpha-diversity analysis of the intestinal flora showed significant differences among the three groups, with a significant reduction in population diversity in the M group and a recovery of population diversity after arecoline treatment. At the phylum level, the relative abundance of Firmicutes was significantly higher in the T group and Proteobacteria in the M group. The KEGG metabolic pathways included polyketide sugar unit biosynthesis and hypertrophic cardiomyopathy. Thirty-three significantly different metabolites were identified among the groups. Significantly different metabolites between groups T and M included indolepyruvate, 2-deoxystreptamine, sakuranetin, glycyl-leucine, and riboflavin. The KEGG metabolic pathway suggested a potential role for arachidonic acid metabolism, serotonergic synapses, neuroactive ligand-receptor interactions, tyrosine metabolism, and regiomelanin. Vitamin digestion and absorption, as well as regulation of lipolysis in adipocytes, were the main metabolic pathways that distinguished the T vs. M groups. PGE2 is involved in several metabolic pathways. Correlation analysis showed that 29 bacterial species were significantly associated with PGE2 levels in the M and T groups. Vagococcus , Lawsonia , Christensenella , unidentified Erysipelotrichaceae , unidentified Coriobacteriaceae , and five other bacterial groups are unique in the PGE2 metabolic pathway regulated by arecoline. Discussion: Arecoline has lipid-lowering effects and may exert therapeutic effects in NAFLD through intestinal metabolites and intestinal flora, as well as through the Butyricicoccus / Christensenella / Coriobacteriaceae -COX2/PGE2 pathway. Thus, arecoline may represent a potential drug or target for NAFLD treatment.

Metabonomic study on the effects of allicin on rats

NMR-based Metabonomic Studies on Urine and Serum from Pr(NO3)(3)-treated Rats

Nuclear Magnetic Resonance-based Metabonomic Studies on Urine and Serum from Pr(NO3)a-treated Rats

Metabolic Profiling Studies On The Toxicological Effects Of Realgar In Rats By H-1 Nmr Spectroscopy

NMR spectroscopic-based metabonomic investigation on the acute biochemical effects induced by Ce(NO3)3 in rats.

Studies on the acute biochemical effects of Nd(NO 3) 3 by nuclear magnetic resonance-based metabonomics

Metabonomic Studies on Intact Livers and Liver Extracts from Rats Treated with Neodymium Nitrate

Allicin Protects Renal Function, Improves Oxidative Stress and Lipid Peroxidation in Rats with Chronic Renal Failure

Study on the inhibitive effect of allicin on esophageal carcinoma in rats induced by different concentration of NMBA

Current studies and potential future research directions on biological effects and related mechanisms of allicin

Allicin Alleviates Mitochondrial Dysfunction in Acrylamide-Induced Rat Kidney Involving the Regulation of SIRT1

Protective Effect of Allicin on Intestinal Mucosal Barrier of Septic Rats

Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.

Metabonomic study of aristolochic acid-induced nephrotoxicity in rats.

The effect of allicin on blood and tissue lead content in mice

Metabolic Regulation Mechanism of Aconiti Radix Cocta Extract in Rats Based on 1H-NMR Metabonomics

Allicin ameliorates glucose and lipid metabolism via modulation of gut microbiota and bile acid profile in diabetic rats

Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat.

Gut metabolomics and 16S rRNA sequencing analysis of the effects of arecoline on non-alcoholic fatty liver disease in rats

Allicin Improves Metabolism in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiota

Potential protective effects of oral administration of allicin on acrylamide-induced toxicity in male mice